Kim et al. showed that among CD8+ TILs, extracted from hepatocellular carcinoma (HCC) patients, 4-1BB+ PD-1high Tc TILs exhibit significantly higher levels of tumor reactivity than 4-1BB− PD-1high Tc [166]. This evidence concerns the gene CD8A and neoplasm.